Global health equity news & press releases
The challenge to address health inequities
Johnson & Johnson selects winners of the 2024 Health Equity Innovation Challenge that aims to address health inequities
What to know about We All Belong: 2023 DEI Impact Review
The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.
4 things to know about Johnson & Johnson’s 2023 Health for Humanity Report
The annual report details the company’s ongoing work in helping to create a healthier world, building a more diverse and inclusive workforce, championing global health equity and more.
Building climate-resilient health clinics
When Mother Nature strikes—think triple-digit heatwaves, wildfires, hurricanes—vulnerable populations are at risk of missing out on much-needed healthcare. For Earth Day, learn how Johnson & Johnson is helping community clinics protect patients.
Dr. Daphne Chan is helping to improve clinical trial diversity through the J&J VISIBLE study
Johnson & Johnson Our Race to Health Equity is profiling the people at the heart of the company who are working to make a more equitable world possible through its Health Equity Champion Spotlight series.
Finding harmony at the intersection of health and hip-hop
Uniting music industry icons with health and wellness experts, “the mibo show” podcast offers a trusted and refreshingly candid take on a range of health issues impacting communities of color.
Inside the science of strokes
Strokes are responsible for around 140,000 deaths a year in the United States alone. For Stroke Awareness Month, learn how Johnson & Johnson is innovating to help change that stat.
Janssen Announces Promising Antiviral Activity Against Dengue in a Phase 2a Human Challenge Model
The antiviral JNJ-1802 induced prophylactic antiviral activity against dengue in a human challenge model Dengue infects millions of people annually and could impact many more as climate change fuels outbreaks The antiviral, previously found to be safe and well-tolerated, is now in a community-based field study to establish efficacy in a real-world setting
Health Equity Champion spotlight: How Dr. Yolanda Lawson fosters inclusion through clinical trial diversity
Our Race to Health Equity is partnering with National Medical Fellowships to address health inequities and help make the next generation of physicians as diverse as the patients they serve. Through this series, we’re profiling people at the heart of Johnson & Johnson who are working to eliminate persistent gaps and create more effective and equitable health systems.
Health equity champion spotlight: For Heather McLaughlin and London Wills, advocacy is personal
Through this series, Our Race to Health Equity is featuring people at the heart of Johnson & Johnson who are working to make a more equitable world possible.
How Johnson & Johnson is helping build a sense of belonging by investing in student nurses of color
A diverse nursing workforce is a better nursing workforce—one that improves quality of care and patient outcomes for all populations. That’s why Johnson & Johnson has put its support behind two pilot programs aimed at setting nurses up for success on campus and in healthcare settings.
My Health Can’t Wait: Working to close the racial health gap through meaningful partnerships and a community-first approach
Johnson & Johnson recently partnered with two Philadelphia community organizations to support the launch of My Health Can’t Wait, a community wellness initiative connecting people of color with vital health information and resources.
Driving diversity in medical illustration
In honor of Juneteeth, learn how a new online database supported by Johnson & Johnson aims to promote racial health equity by increasing imagery of people of color.
CARVYKTI® (ciltacabtagene autoleucel) Reduces Risk of Disease Progression or Death by 74 Percent in Earlier-Line Multiple Myeloma Treatment in the Landmark Phase 3 CARTITUDE-4 Study
At 16-months median follow-up, CARVYKTI® significantly improved progression-free survival compared to two standard treatmentsi Data presented at the 2023 ASCO and EHA Annual Meetings and published in The New England Journal of Medicine
Meet 3 Johnson & Johnson climate champions
For Earth Day—and as Johnson & Johnson continues to make significant progress toward meeting its climate goals—learn about some of the employees who are working to impact both human health and the health of the planet.
Advancing unconscious bias training for healthcare professionals
With support from the Our Race to Health Equity Business Matching Fund, Johnson & Johnson Institute and CME Outfitters are training healthcare professionals to recognize and address inequities in healthcare to improve patient care for historically marginalized individuals.
5 things we now know about peripheral artery disease
The common circulatory condition is a leading cause of amputations in the U.S. Learn why Black Americans are disproportionately affected and how Johnson & Johnson is helping to raise awareness about the disease.
Advancing diversity: 3 healthcare experts share their career stories
The statistics are stark: People of color are vastly underrepresented in medical and scientific professions. But various programs—including ones sponsored by Johnson & Johnson—are working to help level the playing field.
“As black men, we keep things close to the hip": 5 questions for a urologist about prostate cancer
The goal to eliminate prostate cancer starts with getting people to talk about it—especially Black men, who are two times more likely to die from the disease than most other men. For Men’s Health Week, we spoke with a physician about building awareness and normalizing tough conversations.
2 big ideas to help lower the risk of maternal-fetal complications in BIPOC women
Women from historically underrepresented communities have a higher risk of pregnancy complications. So Johnson & Johnson Innovation challenged researchers to propose potential solutions that aim to address this troubling healthcare disparity. These awardees just might be the game changers.